alpinia
officinarum
hanc
zingiberacea
known
lesser
galang
wellknown
medicin
herb
distribut
east
asia
whose
rhizom
use
stomach
analges
antiemet
treatment
plant
grow
sever
feet
tall
long
leav
reddishwhit
flower
alpinia
officinarum
wide
cultiv
throughout
china
thailand
india
sri
lanka
malaysia
indonesia
saudi
arabia
egypt
speci
nativ
asia
australia
pacif
island
occur
tropic
subtrop
climat
alpinia
largest
genu
speci
zingiberacea
histor
rhizom
possess
stimul
digest
effect
owe
spici
flavor
aromat
scent
result
wide
use
curri
perfum
throughout
asia
although
previous
use
throughout
europ
use
declin
recent
year
mainli
use
eastern
europ
homoeopath
use
stimul
rhizom
officinarum
use
tradit
japanes
herbal
prescript
kampo
medicin
mainli
dyspepsia
vomit
flatul
stomach
troubl
diarrhea
plant
also
use
tradit
chines
medicin
aphrodisiac
abortifaci
carmin
antipyret
antiinflammatori
emmenagogu
well
treat
disord
heart
kidney
bronchiti
chronic
enter
renal
calculu
diabet
rheumat
furthermor
rhizom
use
variou
asian
cuisin
exampl
thai
lao
tom
yum
tom
kha
gai
soup
vietnames
hu
cuisin
throughout
indonesian
cuisin
rhizom
contain
numer
activ
constitu
includ
essenti
oil
resin
flavonoid
diarylheptanoid
phenylpropanoid
main
compon
distribut
genu
diarylheptanoid
possess
cytotox
antiemet
antiinflammatori
antiviru
antiprolif
activ
rhizom
officinarum
import
medicin
herb
record
chines
korean
japanes
pharmacopoeia
chapter
discuss
biolog
activ
natur
diarylheptanoid
isol
officinarum
well
synthet
diarylheptanoid
diarylheptanoid
major
class
bioactiv
constitu
officinarum
categor
linear
cyclic
dimer
diarylheptanoid
diarylheptanoid
bear
special
moieti
fig
tabl
diarylheptanoid
isol
officinarum
mainli
linear
diarylheptanoid
diarylheptanoid
mostli
possess
common
structur
moieti
group
heptan
skeleton
main
type
linear
diarylheptanoid
possess
group
structur
differ
structur
lie
pattern
substitut
aromat
ring
diarylheptanoid
possess
common
structur
moieti
heptan
skeleton
addit
compound
also
linear
diarylheptanoid
possess
doubl
bond
keton
group
sun
sever
novel
dimer
diarylheptanoid
isol
rhizom
officinarum
dimer
diarylheptanoid
connect
cdc
cdodc
bond
connect
pyridin
ring
sixnumb
carbon
ring
pyridin
officinin
sixnumb
carbon
ring
deriv
heptan
unit
linear
diarylheptanoid
liang
et
al
found
diarylheptanoid
novel
skeleton
bear
flavonol
moieti
pharmacolog
research
found
diarylheptanoid
exhibit
antiprolif
cytotox
antiemet
antiinflammatori
antiviru
activ
mani
relat
diarylheptanoid
examin
order
studi
structureact
relationship
sar
sever
research
group
develop
techniqu
detect
isol
identif
compon
officinarum
wong
et
al
isol
two
diarylheptanoid
two
flavonoid
use
highspe
countercurr
chromatographi
hsccc
chloroform
extract
ho
et
al
attempt
analyz
ethyl
acet
extract
directli
highperform
liquid
chromatographi
hplc
photodiod
array
electrochem
detect
hplcecd
techniqu
hplcedc
method
also
power
tool
detect
diarylheptanoid
compon
nanogram
level
furthermor
feng
et
al
discuss
separ
identif
diarylheptanoid
supercrit
fluid
extract
officinarum
use
uplcqtofmsm
system
diarylheptanoid
wide
distribut
natur
curcumin
common
diarylheptanoid
possess
rang
bioactiv
human
diseas
includ
antitumor
antiinflammatori
antioxid
activ
hand
yashabushidiol
isol
male
flower
alnu
sieboldiana
betulacea
hashimoto
et
al
compound
also
includ
diarylheptanoid
officinarum
compound
fig
stereoselect
synthesi
yashabushidiol
deriv
report
venkateswarlu
group
shind
group
yikang
group
group
use
sugar
deriv
start
materi
exampl
dmannitol
dglucos
dgluconolacton
sever
step
acet
compound
obtain
nucleophil
addit
wittig
reaction
afford
yashabushidiol
deriv
fig
also
synthes
yashabushidiol
deriv
use
kinet
resolut
sharpless
asymmetr
epoxid
reaction
fig
first
treat
nbuli
follow
addit
lithiat
alkynyl
solut
reduct
propargyl
alcohol
redal
afford
racem
allyl
alcohol
sharpless
epoxid
reaction
allyl
alcohol
gave
enantioenrich
antiepoxi
alcohol
kinet
resolut
follow
reduct
use
redal
afford
natur
unnatur
type
yashabushidiol
b
hand
racem
allyl
alcohol
treat
mcpba
preferenti
gener
synepoxi
alcohol
follow
reduct
use
cp
ticl
zn
zncl
afford
yashabushidiol
compound
enantiom
synthes
almost
condit
compound
show
particularli
strong
antivir
activ
respiratori
syncyti
viru
rsv
vitro
vivo
optic
activ
compound
synthes
racem
allyl
alcohol
accord
follow
procedur
first
kinet
resolut
optic
activ
epoxi
alcohol
chiral
allyl
alcohol
perform
sharpless
asymmetr
epoxid
sharpless
ae
chiral
allyl
alcohol
subject
sharpless
ae
ldipt
afford
opposit
configur
epoxi
alcohol
epoxi
alcohol
oxid
dessmartin
periodinan
oxid
afford
optic
activ
keton
final
compound
enantiom
obtain
treat
keton
meotf
deprotect
keton
tbaf
yield
compound
fig
compound
also
isol
officinarum
resembl
structur
yashabushidiol
b
synthes
da
et
al
also
use
kinet
resolut
sharpless
ae
reaction
racem
allyl
alcohol
follow
ring
open
reaction
compound
protect
acid
condit
follow
deprotect
pmb
group
use
ddq
reagent
final
termin
hydroxyl
group
oxid
swern
oxid
afford
aldehyd
compound
subject
wittig
reaction
follow
reduct
use
h
pd
carbon
yield
compound
fig
alpinoid
b
c
also
isol
officinarum
sun
et
al
compound
uniqu
moieti
skeleton
carbon
chain
gener
diarylheptanoid
possess
structur
alpinoid
b
c
moieti
addit
chiral
center
absolut
configur
determin
r
mosher
method
alpinoid
c
analogu
synthes
venkateswarlu
group
miura
group
synthet
strategi
venkateswarlu
group
describ
fig
first
treat
dipt
ti
oipr
cumen
hydroperoxid
afford
chiral
epoxi
alcohol
two
step
epoxi
alcohol
form
chiral
allyl
alcohol
follow
olefin
metathesi
coupl
use
grubb
second
gener
catalyst
afford
alpinoid
c
hand
miura
et
al
synthes
use
asymmetr
rearrang
chiral
enon
fig
chiral
enon
readili
synthes
lmenthyl
sulfin
chiral
enon
treat
catalyt
amount
dbu
pph
follow
oxid
aqueou
h
solut
afford
target
compound
high
enantiomer
excess
neuroblastoma
common
extracrani
pediatr
solid
tumor
account
tumor
pediatr
age
group
clinic
present
neuroblastoma
variabl
advanc
case
often
found
highli
resist
convent
treatment
modal
base
surgeri
chemotherapi
transplant
radiotherapi
thu
develop
new
effect
safe
therapeut
agent
treatment
neuroblastoma
urgent
need
recent
public
discuss
antitumor
activ
natur
occur
compound
neuroblastoma
compound
exhibit
potent
activ
neuroblastoma
cell
tabl
ic
valu
respect
potent
cisplatin
ic
sun
et
al
found
diarylheptanoid
contain
substitu
benzen
ring
carbonyl
doubl
bond
aliphat
chain
possess
potent
cytotox
cell
line
dosedepend
manner
found
induc
phase
arrest
apoptosi
via
upregul
activ
transcript
factor
stabil
cell
line
compound
also
exhibit
potent
cytotox
atcc
human
cancer
cell
line
ic
furthermor
matsuda
et
al
also
test
inhibit
melanogenesi
theophyllinestimul
melanoma
cell
found
ic
valu
compound
show
strongest
activ
among
four
diarylheptanoid
ic
also
inhibit
mrna
express
tyrosinas
tyrosinaserel
protein
trp
well
protein
level
microphthalmiaassoci
transcript
factor
mitf
chronic
inflamm
may
caus
factor
varieti
cancer
longer
inflamm
persist
higher
risk
cancer
gener
inflammatori
leukocyt
neutrophil
monocyt
macrophag
eosinophil
provid
solubl
factor
thought
mediat
develop
inflammationassoci
cancer
includ
cancer
cell
although
cell
also
particip
inflammatori
mediat
includ
metabolit
arachidon
acid
cytokin
chemokin
free
radic
chronic
exposur
mediat
lead
increas
cell
prolifer
mutagenesi
oncogen
activ
angiogenesi
emphasi
place
examin
role
reactiv
oxygen
eg
nitrogen
intermedi
eg
cytokin
eg
interferon
interleukin
tumor
necrosi
prostaglandin
pg
increas
cancer
incid
associ
increas
durat
inflamm
anim
model
demonstr
experiment
chronic
inflamm
lead
develop
variou
form
cancer
provid
insight
possibl
mechan
skin
tumor
induc
administr
carcinogen
anthracen
dmba
follow
repeat
administr
tumor
promot
tpa
recent
public
discuss
inflammatori
tumor
promot
inhibitor
natur
occur
compound
methanol
extract
rhizom
officinarum
inhibit
tumor
promot
tpa
initi
dmba
icr
mice
fig
show
percentag
tumorbear
mice
treat
dmba
plu
tpa
week
wherea
group
treat
dmba
plu
tpa
methanol
extract
officinarum
treatment
methanol
extract
rhizom
officinarum
caus
reduct
averag
number
tumor
per
mous
week
fig
use
bioassayguid
isol
seven
diarylheptanoid
isol
activ
fraction
methanol
extract
officinarum
inhibitori
effect
tpainduc
inflamm
close
parallel
inhibit
tumor
promot
twostag
carcinogenesi
initi
dmba
tpa
wellknown
tumor
promot
mous
skin
model
diarylheptanoid
inhibit
tumor
promot
twostag
carcinogenesi
mous
skin
hand
diarylheptanoid
inhibit
tpainduc
inflamm
mice
tabl
compound
similar
activ
indomethacin
inflammatori
drug
antiinflammatori
mechan
diarylheptanoid
report
mani
research
matsuda
et
al
found
compound
inhibit
nitric
oxid
product
lipopolysaccharid
lp
activ
mous
periton
macrophag
bioassayguid
isol
compound
show
particularli
strong
inhibitori
activ
ic
valu
bioassayguid
purif
ether
extract
led
isol
new
diarylheptanoid
well
two
known
diarylheptanoid
compound
exhibit
potent
plateletactiv
factor
paf
receptor
bind
inhibitori
activ
ic
valu
respect
compound
also
show
inhibitori
bactericid
activ
enteropathogen
escherichia
coli
epec
clinic
isol
effici
suppress
epec
lpsinduc
inflamm
human
peripher
blood
mononuclear
cell
compound
exhibit
antiinflammatori
properti
mous
macrophag
cell
line
raw
suppress
lpsinduc
product
interleukin
il
inhibit
nuclear
activ
phosphoryl
mitogenactiv
protein
kinas
mapk
compound
test
inhibitori
effect
product
lpsactiv
macrophag
cell
line
raw
compound
show
potent
inhibitori
activ
ic
valu
respect
diarylheptanoid
isol
nhexan
extract
modul
signal
involv
inflammatori
respons
inhibit
lpsinduc
express
nitric
oxid
synthas
no
gene
level
raw
cell
kiuchi
et
al
examin
effect
diarylheptanoid
pg
leukotrien
suggest
compound
lack
methoxi
group
adjac
phenol
less
activ
possess
methoxi
group
presum
owe
decreas
acid
phenol
group
thu
report
cite
suggest
diarylheptanoid
possess
inhibitori
effect
inflammatori
tumorpromot
activ
diarylheptanoid
exhibit
antivir
activ
influenza
viru
rsv
polioviru
measl
viru
herp
simplex
viru
type
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
sar
viru
epsteinbarr
viru
relat
carcinogenesi
character
compound
possess
broad
antivir
spectrum
dna
rna
virus
diarylheptanoid
possess
antivir
activ
evalu
vitro
antivir
activ
vivo
document
influenza
viru
rsv
use
anim
infect
model
sawamura
et
al
examin
antiinfluenza
viru
activ
cytotox
diarylheptanoid
isol
officinarum
plaqu
reduct
assay
mtt
assay
respect
use
madindarbi
canin
kidney
mdck
cell
tabl
studi
influenza
viru
suscept
ec
ec
other
therapeut
index
cc
ed
respect
compound
moieti
platyphyllon
contain
two
moieti
report
activ
influenza
viru
therapeut
index
thu
hydroxyl
posit
phenyl
moieti
may
import
antiinfluenza
viru
activ
vitro
howev
murin
influenza
viru
infect
model
significantli
reduc
viru
titer
bronchoalveolar
lavag
fluid
lung
prolong
surviv
time
infect
mice
without
toxic
wherea
show
activ
compound
possess
unsatur
keton
methoxi
group
posit
moieti
thu
keton
methoxi
group
may
necessari
antiinfluenza
activ
vivo
compound
exhibit
antivir
activ
viru
viru
b
type
viru
well
oseltamivirresist
viru
indic
mode
antiinfluenza
viru
action
differ
known
agent
oseltamivir
suggest
candid
antivir
compound
virul
strain
pandem
fact
shown
effect
viru
adsorpt
invas
cell
instead
suppress
express
viral
messeng
rna
antigen
infect
mdck
cell
probabl
select
suppress
influenza
viru
mrna
synthesi
infect
cell
without
cytotox
diarylheptanoid
isol
alpinia
katsumadai
katsumadain
e
e
report
inhibitori
activ
neuraminidas
na
influenza
viru
vitro
diarylheptanoid
isol
officinarum
may
therefor
effect
reduc
na
activ
konno
et
al
tabl
among
effect
strain
rsv
ec
valu
tabl
respect
compound
show
antivir
activ
strain
rsv
therapeut
index
respect
potent
test
compound
compound
also
activ
influenza
viru
ec
valu
suggest
effect
diarylheptanoid
rsv
influenza
viru
vitro
compound
synthes
enantiom
racem
respect
compound
synthes
enantiom
fig
therapeut
index
stereoisom
similar
cc
ec
respect
ec
valu
tabl
respect
howev
therapeut
index
higher
three
stereoisom
ec
valu
respect
posit
methoxyl
satur
keton
posit
compound
also
contain
methoxi
group
satur
keton
ec
valu
thu
methoxyl
diarylheptanoid
may
contribut
antirsv
activ
vitro
murin
intranas
rsv
infect
model
compound
significantli
effect
reduc
viru
titer
infiltr
lymphocyt
level
marker
pneumonia
sever
lung
mice
among
show
strongest
antirsv
activ
mice
shown
antirsv
assay
vitro
may
lead
compound
develop
antirsv
drug
futur
six
diarylheptanoid
examin
antirsv
activ
polioviru
measl
viru
plaqu
reduct
assay
trypan
blue
dye
exclus
assay
use
vero
cell
tabl
among
six
compound
exhibit
signific
antirsv
activ
cell
howev
exhibit
rel
stronger
antivir
activ
three
virus
polioviru
measl
viru
effect
measl
viru
examin
diarylheptanoid
except
exhibit
antipolioviru
activ
ec
valu
except
exhibit
activ
ec
valu
tabl
six
examin
compound
significantli
effect
measl
viru
ec
valu
thu
diarylheptanoid
appear
broad
spectrum
antivir
activ
chareonkla
et
al
report
heptan
zingib
mekongens
exhibit
antihiv
activ
antisyncytium
assay
use
viru
cell
line
system
show
activ
revers
transcriptas
assay
hirsutenon
isol
alnu
japonica
shown
potent
inhibitor
papainlik
proteas
control
replic
sar
coronaviru
compound
therefor
thought
potenti
compound
treatment
sar
cyclic
diarylheptanoid
isol
acer
nikoens
myrica
rubra
report
strongli
inhibit
epsteinbarr
viru
earli
antigen
activ
raji
cell
also
exhibit
inhibitori
activ
mous
skin
tumor
promot
vivo
twostag
carcinogenesi
test
possibl
diarylheptanoid
officinarum
possess
antivir
activ
virus
obes
major
health
concern
present
wide
consid
global
epidem
convent
allopath
medicin
use
treat
obes
high
abus
potenti
frequent
exhibit
side
effect
botan
includ
natur
weight
loss
product
thoroughli
research
basic
clinic
level
thu
imper
valid
widespread
consumpt
weight
manag
mani
natur
weight
loss
product
sold
use
global
littl
proof
efficaci
qualiti
concern
regard
safeti
surfac
good
reason
orlistat
inhibit
pancreat
gastric
lipas
catalyz
hydrolysi
ingest
fat
result
reduc
dietari
fat
absorpt
high
fecal
fat
excret
certain
orlistat
mark
drug
effect
energi
intak
western
diet
attribut
dietari
fat
howev
malabsorpt
fat
lead
rather
uncomfort
side
effect
flatu
discharg
oil
spot
rectum
fecal
incontin
fecal
urgenc
loos
liquid
stool
malabsorpt
fatsolubl
vitamin
water
extract
rhizom
officinarum
show
strongest
inhibitori
activ
pancreat
lipas
vitro
extract
subsequ
fraction
use
organ
solvent
ethyl
acet
fraction
strongest
inhibitori
activ
potent
inhibitor
fraction
identifi
ether
fig
ic
valu
mg
ml
compar
posit
control
orlistat
ic
valu
mgml
use
triolein
substrat
oral
administr
corn
oil
triglycerid
level
mice
decreas
significantli
less
control
group
administr
h
extract
gkg
ethyl
acet
fraction
gkg
triton
hyperlipidem
mice
ether
significantli
decreas
triglycerid
cholesterol
level
mgkg
dose
respect
increas
high
densiti
lipoprotein
hdl
compar
control
group
moreov
ether
show
hypolipidem
activ
high
cholesterol
dietinduc
hyperlipidem
mice
compound
exhibit
inhibitori
activ
pancreat
lipas
ic
valu
mgml
use
triolein
substrat
level
serum
triglycerid
corn
oil
fed
mice
reduc
significantli
level
serum
triglycerid
cholesterol
reduc
triton
hyperlipidem
mice
hypolipidem
activ
observ
highcholesterol
dietinduc
hyperlipidem
mice
inhibit
pancreat
lipas
compound
compar
posit
control
orlistat
good
term
paramet
triglycerid
cholesterol
hdl
level
howev
orlistat
remain
effect
drug
antiemet
drug
effect
vomit
nausea
may
use
sever
case
gastroenter
particularli
patient
dehydr
antiemet
also
use
morn
sick
littl
inform
effect
fetu
crude
drug
inhibit
vomit
among
tradit
japanes
herbal
prescript
officinarum
use
antiemet
tradit
chines
medicin
takahashi
et
al
report
diarylheptanoid
show
antiemet
activ
copper
sulfat
cuso
induc
emesi
assay
young
chick
sar
diarylheptanoid
also
investig
among
diarylheptanoid
two
type
essenti
function
structur
show
inhibitori
activ
emesi
diarylheptanoid
contain
partial
type
b
structur
fig
therefor
conclud
diarylheptanoid
type
b
might
main
antiemet
compon
officinarum
reduc
nicotinamid
adenin
dinucleotid
phosphat
present
type
type
isozym
human
rat
catalyz
reduct
convers
testosteron
act
activ
androgen
testosteron
mani
tissu
prostat
therefor
inhibitor
enzymat
convers
may
use
select
treatment
androgendepend
diseas
benign
prostat
hyperplasia
male
pattern
bald
acn
inhibitor
steroid
bind
steroid
receptor
steroid
may
produc
variou
undesir
hormon
effect
act
agonist
antagonist
report
diarylheptanoid
possess
inhibitori
activ
sar
four
diarylheptanoid
officinarum
discuss
suggest
diarylheptanoid
unsatur
bond
particularli
conjug
form
alkyl
structur
moieti
two
aryl
group
weak
inhibitori
activ
diarylheptanoid
satur
counterpart
bond
potent
inhibitori
activ
thu
alkyl
part
diarylheptanoid
appear
import
structur
moieti
inhibitori
activ
helicobact
pylori
gramneg
microaerophil
bacterium
found
stomach
also
relat
develop
duoden
ulcer
stomach
cancer
erad
h
pylori
effect
prevent
duoden
ulcer
stomach
cancer
lee
et
al
examin
inhibitori
effect
compound
h
pylori
atcc
atcc
atcc
use
paperdisc
diffus
agar
dilut
method
rhizomederiv
materi
particularli
isol
diarylheptanoid
merit
studi
potenti
antipylori
function
food
product
therapeut
product
prevent
diseas
caus
h
pylori
zhang
ic
valu
compound
hpsydney
strain
respect
bacteria
vertebr
cell
chang
pattern
gene
express
respond
microenviron
addit
classic
dna
microarray
technolog
transcriptom
analysi
new
analyt
tool
highthroughput
screen
whole
transcriptom
sequenc
polysom
profil
translatom
analysi
ribosom
profil
ribosom
protect
assay
recent
emerg
appli
analysi
gene
express
fig
et
al
report
microarray
global
gene
express
analysi
show
acet
fig
novel
phenylpropanoid
alpinia
conchigera
enhanc
apoptot
effect
paclitaxel
cell
inactiv
suggest
induct
tumor
cell
death
apoptosi
modul
dysregul
pathway
genet
inform
transform
dna
protein
cellular
abund
protein
predominantli
control
translat
level
weak
correl
messeng
rna
mrna
protein
level
observ
nontransl
mrna
may
present
rna
granul
rna
particl
process
bodi
stress
granul
mirnarisc
mirisc
complex
cytosol
fig
analysi
translatom
thu
provid
substanti
surpris
new
inform
whole
free
polysom
andor
membranebound
polysom
analysi
also
appli
ribosomeassoci
mrna
usual
separ
mrna
associ
fewer
ribosom
polysomeassoci
mrna
appli
label
probe
dna
microarray
translatom
analysi
sequenc
use
nextgener
sequenc
polysom
profil
polysomeassoci
mrna
appli
ribosomeprotect
assay
result
segment
rna
sequenc
use
nextgener
sequenc
ribosom
profil
analys
activ
stall
ribosom
shown
cosedi
isol
polysom
complex
sucros
gradient
thu
indic
polysom
profil
fulli
distinguish
translat
activ
repress
mrna
diarylheptanoid
inhibit
proinflammatori
mediat
exhibit
cytotox
antivir
activ
howev
precis
mechan
action
effect
express
specif
gene
unknown
thu
use
translatom
analysi
investig
mechan
mode
action
diarylheptanoid
polysomeassoci
mrna
prepar
diarylheptanoidtr
control
cell
human
b
lymphoblastoid
cell
line
mrna
sampl
use
microarray
analysi
number
downregul
inflammatoryrel
transcript
rank
follow
compound
show
greater
influenc
translatom
bjab
cell
show
less
efficaci
except
upregul
express
gene
relat
rhodopsinlik
gpcr
mrna
process
proteasomerel
protein
wikipathway
possibl
host
factor
splice
factor
hnrnp
list
mrna
process
wp
wikipathway
affect
viru
structur
andor
replic
sixteen
transcript
upregul
treatment
among
transcript
heterogen
nuclear
ribonucleoprotein
c
heterogen
nuclear
ribonucleoprotein
k
nonpou
domain
contain
octamerbind
polypyrimidin
tractbind
protein
identifi
intern
ribosom
entri
site
transact
factor
studi
provid
new
insight
mode
action
diarylheptanoid
officinarum
regard
antiinflammatori
antitumor
promot
antivir
effect
human
use
plant
food
natur
medicin
sinc
ancient
time
crude
drug
typic
safer
synthet
drug
use
spice
supplement
sever
activ
compon
isol
chemic
structur
continu
determin
diarylheptanoid
rhizom
officinarum
consid
particularli
promis
group
compound
diarylheptanoid
minor
ubiquit
compon
diet
advantag
nontox
rel
nontox
human
natur
diarylheptanoid
multipl
physiolog
function
includ
antiinflammatori
antitumor
cancer
prevent
antivir
antiemet
antipylori
effect
challeng
must
overcom
order
find
function
use
compound
appli
clinic
screen
natur
diarylheptanoid
compound
examin
sar
elucid
physiolog
action
mechan
problem
associ
suppli
larg
quantiti
compound
order
resolv
issu
collabor
research
variou
field
necessari
activ
activ
transcript
factor
bjab
human
blymphoma
cell
line
